Research is a core mission of the Division of Rheumatology, with a growing portfolio spanning translational science, clinical trials and outcomes research.
Key Focus Areas:
- Synovial tissue biology and the pathobiology of inflammatory arthritis.
- Precision medicine and biomarker discovery.
- Treatment response stratification.
- Health outcomes and quality improvement in rheumatic diseases.
Clinical Trials Program:
The division actively participates in both industry-sponsored and investigator-initiated clinical trials evaluating novel therapeutics in:
- Lupus nephritis.
- Interstitial lung disease.
- Scleroderma.
Research infrastructure supports patient recruitment, regulatory compliance and dedicated research coordination.
Collaborations:
The division is expanding partnerships with immunology, nephrology and pulmonology to foster multidisciplinary translational research.
Vision:
The long-term vision is to establish a Center of Excellence in synovial tissue research and novel drug discovery through clinical trials, contributing to therapeutic development and advancing targeted therapies in inflammatory arthritis.